The read at a glance
Computed from the FY2026 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 9.22 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.58 — no flag raisedOK
- Earnings quality 98/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2026, as RESMED INC reports it. History and quarterly detail are in the app.
- Sleep and Breathing Health$5.0B
- Residential Care Software$675.8M
Leadership changes
From RESMED INC's own filings, the day they're filed.
- Aaron Bloomer · Chief Financial Officer · appointmenteff. 2026-05-04
- Nicole Mowad-Nassar · Directors · departureeff. 2025-08-15
- Expected Retirement · Directors · departureeff. 2025-08-15
Latest filings
- 8-K · Company announcement2026-09-01
- 8-K · Company announcement2026-08-17
- 10-K · Annual report2026-08-13
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-07-07
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about RESMED INC, every answer cited to the official filings🔒
- The Intelligence Brief — added when RESMED INC's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.